ESR1 and breast carcinoma: Previous studies showed that MCDF is used as an agent in the treatment of breast cancer by inhibiting 17β-estradiol (E2)-induced cell proliferation, tumor growth and prevents E2-induced increase in ER and progesterone receptor [3], [6].